NEUKINE 300MCG INJ.
It is marketed by Amgen with the brand name Neupogen, Reliance Biopharmaceuticals with the brand name Religrast and also by Zenotech Laboratories Limited with the brand name Nugraf.
Indications: Mobilisation of peripheral blood progenitor cells for autologous peripheral blood stem cell transplantation.
Idiopathic or cyclic neutropenia.
HIV infection and persistent neutropenia.
Adjunct to antineoplastic therapy.
Bone marrow transplantation.